Cor et Vasa Case Reports

Miloš Táborský

Cor Vasa 2018, 60(2):235  

Role of echocardiography and cardiac biomarkers in prediction of in-hospital mortality and long-term risk of brain infarction in pulmonary embolism patients

David Vindiš, Martin Hutyra, Daniel Šaňák, Michal Král, Eva Čecháková, Jana Zapletalová, Simona Littnerová, Tomáš Adam, Jan Přeček, Miloš Táborský

Cor Vasa 2018, 60(2):e105-e113 | DOI: 10.1016/j.crvasa.2017.04.003  

Introduction: The aim of prospective study was to evaluate the ability of echocardiography and cardiac biomarkers to predict in-hospital mortality and the risk of brain infarction during a 12-month follow-up period (FUP) with anticoagulation in pulmonary embolism (PE) patients.Methods: Eighty-eight consecutive acute PE patients (39 men, mean age 63 years) were enrolled; 78 underwent baseline echocardiography and brain magnetic resonance imaging (MRI). After a 12-month FUP, 58 underwent brain MRI. In-hospital mortality and the rates of new ischemic brain lesions (IBL) on MRI with clinical ischemic stroke (IS) events were predicted based on echocardiography...

Late outcomes after interventional treatment - Successful stenting of Takayasu arteritis lesions. Single center experience in Bulgaria

Ivo S. Petrov, Iveta G. Tasheva, Svetlin N. Tsonev, Zoran Stankov, Silvia A. Pavlova, Lachezar N. Grozdisnki

Cor Vasa 2018, 60(2):e114-e121 | DOI: 10.1016/j.crvasa.2017.06.002  

Aim: The studied group included patients at different age and gender with follow-up period at least 1 year. The work represents endovascular treatment of patients with different localization of the disease and according to the target lesion proper endovascular access was selected.Methods and results: The patients are divided into groups, depending on the Numano classification. Seven of studied patients were in age between 33 to 44 years, only 1 was 65 years old, 7 of them were females and one male. The patients were accumulated for the period of one year.Doppler sonography was used for screening of the patients with known Takayasu disease....

Patent hemostasis and comparison of two compression devices after transradial coronary catheterization and intervention

Štěpán Jirouš, Ivo Bernat, Jan Duršpek, Richard Rokyta

Cor Vasa 2018, 60(2):e122-e126 | DOI: 10.1016/j.crvasa.2017.07.003  

Aim: The aim of this study was to compare two compression devices after transradial coronary catheterization and intervention.Methods: Out of 280 consecutive patients who underwent cardiac catheterization and intervention (n = 74) as a part of a same-day discharge program, 140 patients were applied the TR Band (TB) compression device and 140 the Seal-One (SO) compression device. The time needed to achieve patent hemostasis, duration of compression and local complications were assessed.Results: In the TB group, patent hemostasis was achieved in 17.5 ± 10.3 min, in the SO group in 21.4 ± 10.5 min (p = NS). The duration of radial...

The mortality benefit seen with the newer more potent oral P2Y12 inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis

J. Wouter Jukema, Hannes Alber, Petr Widimský

Cor Vasa 2018, 60(2):e127-e132 | DOI: 10.1016/j.crvasa.2017.07.004  

Background: The two newer oral P2Y12 inhibitors prasugrel and ticagrelor have proven superior to clopidogrel in the treatment of acute coronary syndrome (ACS). The extent to which the reduction in mortality seen with ticagrelor is confined to this particular agent is hard to judge by simply looking at the overall study results as the study populations were composed of different cohorts at substantially different risk of death.Methods: A meta-regression technique was applied to 12 distinctive patient cohorts, six for each of prasugrel and ticagrelor, to investigate differential effects on mortality of P2Y12 inhibitors.Results: Data for the analysis...

Valve preserving surgery in patients with bicuspid aortic valve

Jiří Ničovský, Jiří Ondrášek, Petr Fila, Jan Štěrba, Linda Vetešková, Marek Šebo, Petr Němec

Cor Vasa 2018, 60(2):e133-e138 | DOI: 10.1016/j.crvasa.2017.07.005  

Bicuspid aortic valve can be associated with clinically important aortic regurgitation and dilatation of ascending aorta. Aortic valve repair or valve sparing procedures seem to be optimal therapeutic option how to avoid prosthetic valve-related and anticoagulation-related complications. We have analyzed midterm outcomes of patients after bicuspid aortic valve preserving surgery.Material and methods: Between January 2008 and December 2015, 91 patients (mean age 40.9 ± 12.2) with bicuspid aortic valve underwent valve preserving surgery for aortic valve regurgitation and/or aortic aneurysm. Urgent procedures and patients of age more than 65...

Inappropriate left ventricular hypertrophy as a tool for risk stratification in patients with essential hypertension

Sergiy Lozinsky

Cor Vasa 2018, 60(2):e139-e143 | DOI: 10.1016/j.crvasa.2017.07.002  

The alternative method of appropriate left ventricular mass prediction in subjects with normal BP and arterial hypertension was proposed. Also the associations of new indicator of LVM inappropriateness with myocardial infarction, stroke and persistent atrial fibrillation were studied.The study consisted of 2 stages. On the first stage 630 untreated hypertensive patients and 206 normotensive persons were studied using methods of office blood pressure (OBP) measurement, echocardiography, ambulatory blood pressure monitoring (ABPM) and noninvasive central pulse wave analysis (CPWA). Moderate significant correlation (r = 0.58; p = 0.002) between the...

Cardiorenal interactions

Vladimír Tesař, Jan Vachek

Cor Vasa 2018, 60(2):e144-e147 | DOI: 10.1016/j.crvasa.2017.12.006  

Cardiorenal interactions are bidirectional. Renal hypoperfusion in patients with acute or chronic heart disease is associated with increased mortality and increased risk of end-stage renal disease. Heart damage and/or dysfunction in patients with acute and chronic kidney disease have significant negative impact on the patient survival. Awareness and early diagnosis and therapy may help to ameliorate negative consequences of the other organ damage, especially in acute setting. Search for therapeutic interventions aimed at concomitant cardio- and renoprotection is warranted.

Biomarkers of renal function in prognostic stratification of patients with acute coronary syndrome

Jan Přeček, Martin Hutyra, František Kováčik, Jiří Orság, Miloš Táborský

Cor Vasa 2018, 60(2):e148-e154 | DOI: 10.1016/j.crvasa.2017.05.018  

There is close pathophysiological interaction between the kidneys and the heart, affecting, among others, the risk for development and prognosis of many cardiovascular diseases. Early risk stratification of patients with acute coronary syndrome (ACS) is important for optimizing their therapy. Presented is an overview of prognostic stratification of ACS patients according to baseline levels of renal function biomarkers. Apart from classic biomarkers (creatinine, urea) having a dominant role in advanced chronic kidney disease, some novel biomarkers are listed (cystatin C, neutrophil gelatinase-associated lipocalin, interleukin-18) that bring an added...

Management of cardiac sarcoidosis - A practical guide

Petr Kopřiva, Martin Gřiva, Zbyněk Tüdös

Cor Vasa 2018, 60(2):e155-e164 | DOI: 10.1016/j.crvasa.2017.05.012  

Sarcoidosis is a multi-system granulomatous disorder of unclear etiology which can affect any organ of the body including the heart. The heart is involved in up to 25% of sarcoidosis patients. In rare cases, the heart can be the only organ involved.Involvement of the heart, called cardiac sarcoidosis, especially if symptomatic, significantly deteriorates the prognosis for sarcoidosis patients, which is why cardiac sarcoidosis should be not only considered, but also searched for actively. Despite recent advances in this field, diagnosis, risk-stratification, and treatment of cardiac sarcoidosis remains a challenging issue. Fortunately, several recommendations...

Enteric-coated aspirin in cardiac patients: Is it less effective than plain aspirin?

Radovan Jirmář, Petr Widimský

Cor Vasa 2018, 60(2):e165-e168 | DOI: 10.1016/j.crvasa.2017.05.011  

The aim of this review article is to make readers aware of the risk of an inadequate antiplatelet effect of enteric-coated formulations of aspirin. Judging by data from studies published to date and exploring the efficacy of various aspirin formulations, there exist sufficient evidences only of a plain form of aspirin absorbed in the stomach. The implication is that patients with coronary heart disease (CHD) should be treated exclusively with the standard formulation of aspirin.

Carotid endarterectomy during the acute period of ischemic stroke

Peter Berek, Ivan Kopolovets, Vladimír Sihotský, Mária Kubíková, Peter Štefanič, Štefan Tóth, Csaba Dzsinich, Mária Frankovičová

Cor Vasa 2018, 60(2):e169-e173 | DOI: 10.1016/j.crvasa.2017.05.005  

Objective/background: High risk of recurrent ischemic stroke within the first 14 days after index event in patients with atherosclerotic stenosis of the carotid arteries gave the impetus for the revision of the term of performing carotid endarterectomy (CEA) in symptomatic patients. Nowadays the advisability of performing urgent CEA within 72 h after stroke onset in neurologically unstable patients is discussed frequently. The paper presents the evaluation of carotid endarterectomy during the acute period of ischemic stroke.Methods: The results of CEA in 462 patients with symptomatic ICA stenosis performed in two independent Vascular Centers were...

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Summary of the document prepared by the Czech Society of Cardiology and the Czech Society of Angiology

Debora Karetová, Jana Hirmerová, Jiří Matuška

Cor Vasa 2018, 60(2):e183-e204 | DOI: 10.1016/j.crvasa.2018.01.001  

Late infective endocarditis of an Amplatzer atrial septal device twelve years after implantation

Tomáš Toporcer, Adrián Kolesár, Martin Ledecký, František Sabol

Cor Vasa 2018, 60(2):e174-e178 | DOI: 10.1016/j.crvasa.2017.01.006  

Infective endocarditis was initially defined as a disease of patients with pre-existing valvular abnormalities. In contemporary medicine a valvular prosthesis and implanted medical devices are the most common risk factors for infective endocarditis.A case report is presented regarding an 18-year-old female with a medical history of a 12-year implanted Amplatzer occluder. Echocardiography showed an endocarditis focus in the right atrium communicating to the left atrium and destruction of the non-coronary leaflet of the aortic valve, with aortic valve insufficiency. Blood culture was positive for multi-resistant Staphylococcus aureus. The aortic...

Successful treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation

Ingrid Olejárová, Miriam Pavlíková, Michal Hulman, Panagiotis Artemiou, Martin Beňa, Ivo Gašparovič, Vladan Hudec

Cor Vasa 2018, 60(2):e179-e182 | DOI: 10.1016/j.crvasa.2017.01.019  

In the severe form of peripartum cardiomyopathy short- and long-term continuous flow ventricular assist devices offer a safe bridge to transplant where cardiac transplantation seems to be the only hope and treatment end point for most of these patients. In this report we described the outcome of a 33-year-old patient on the 32nd gestational week with peripartum cardiomyopathy who was successfully treated with biventricular mechanical assist devices and cardiac transplantation.

Primary media sclerosis Mönckeberg: Diagnostic criteria

Peter Lanzer

Cor Vasa 2018, 60(2):e205-e208 | DOI: 10.1016/j.crvasa.2017.07.006  

Media sclerosis Mönckeberg (MSM) is associated with progressive calcifications of the arterial wall media leaving the intima intact. MSM is frequently associated with type 2 diabetes mellitus and chronic kidney disease. In some cases, however, no risk factors are present suggesting presence of a primary dystopic calcification disorder. Here we propose diagnostic criteria and advocate dedicated research into this as yet poorly defined vascular disorder.

Podmínky pro provádění diagnostických a léčebných kardiologických invazivních výkonů v režimu jednodenní péče (propuštění ve stejný den nebo ambulantní režim)

Ivo Bernat, David Horák, Martin Mates, Marian Branny, Pavel Červinka, Petr Kala, Petr Kmoníček, Viktor Kočka, Tomáš Kovárník, Ladislav Pešl, Josef Šťásek, Ivo Varvařovský, Michael Želízko

Cor Vasa 2018, 60(2):236-239  

Nová fixní kombinace mezi hypolipidemiky: rosuvastatin plus ezetimib

Cor Vasa 2018, 60(2):245-247  

Debora Karetová, Miroslav Chochola a kolektiv: Vaskulární medicína

MUDr. Jiří Spáčil, CSc.

Cor Vasa 2018, 60(2):248  

Zemřel prof. MUD. Roman Čerbák, CSc., FESC (19. 10. 1933-4. 3. 2018)

Jiří Vítovec, Jindřich Špinar

Cor Vasa 2018, 60(2):240  

Opustil nás pan profesor Roman Čerbák

Michael Aschermann

Cor Vasa 2018, 60(2):241  

Zemřel docent MUDr. Jaroslav Šimíček, CSc. (28. 7. 1931-19. 11. 2017)

Karel Dvořák

Cor Vasa 2018, 60(2):242  

Životní jubileum prof. MUDr. Vladimíra Staňka, CSc., FESC (85 let)

Jiří Widimský

Cor Vasa 2018, 60(2):243  

Významné životní jubileum prof. MUDr. Vladimíra Staňka, CSc., FESC

Michael Aschermann

Cor Vasa 2018, 60(2):244  

Editorial Board

Editorial board

Cor Vasa 2018, 60(2):i | DOI: 10.1016/S0010-8650(18)30038-9